Tadalafil Market Size, Share, By Purity (98%, and Above 98%), By Form (Tablet and Capsule), By Application (Erectile Dysfunction, Benign Prostatic Hyperplasia, and Pulmonary Arterial Hypertension), and By Region (North America, Europe, Asia Pacific, Middle East and Africa, and South America) - Trends, Analysis, and Forecast till 2034

Tadalafil Market Size was valued at USD 6.25 Billion in 2024 and is expected to grow at a CAGR of 11.6% to reach USD 17.00 Billion by 2034.

Tadalafil is a medicine used to treat pulmonary arterial hypertension, benign prostatic hyperplasia, and erectile dysfunction. It is marketed under the trade names Cialis and other names. The oral route is used to ingest it. The length might reach 36 hours, with the usual onset occurring in less than 30 minutes. The generic equivalent of the prescription medication Cialis is called tadalafil. Tadalafil is the active component of generic Cialis. The FDA has approved Cialis for the treatment of BHP and erectile dysfunction (ED). Cialis and generic tadalafil are prescription-only drugs that are used to treat ED.